UNIVERSAL HEALTH SERVICES-B (UHS) Stock Fundamental Analysis
USA - NYSE:UHS - US9139031002 - Common Stock
214.03 USD
+3.35 (+1.59%)
227.6 USD
+13.57 (+6.34%)
UHS gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 101 industry peers in the Health Care Providers & Services industry. UHS has an excellent profitability rating, but there are some minor concerns on its financial health. A decent growth rate in combination with a cheap valuation! Better keep an eye on UHS. These ratings would make UHS suitable for value investing!
1. Profitability
1.1 Basic Checks
In the past year UHS was profitable.
In the past year UHS had a positive cash flow from operations.
Each year in the past 5 years UHS has been profitable.
UHS had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
UHS has a better Return On Assets (8.41%) than 92.08% of its industry peers.
UHS has a better Return On Equity (17.94%) than 85.15% of its industry peers.
Looking at the Return On Invested Capital, with a value of 11.02%, UHS belongs to the top of the industry, outperforming 84.16% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for UHS is in line with the industry average of 9.28%.
The 3 year average ROIC (8.28%) for UHS is below the current ROIC(11.02%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.41% | ||
| ROE | 17.94% | ||
| ROIC | 11.02% |
ROA(3y)6.01%
ROA(5y)6.51%
ROE(3y)13.4%
ROE(5y)14.27%
ROIC(3y)8.28%
ROIC(5y)8.76%
1.3 Margins
UHS has a Profit Margin of 7.66%. This is amongst the best in the industry. UHS outperforms 88.12% of its industry peers.
UHS's Profit Margin has been stable in the last couple of years.
UHS's Operating Margin of 11.01% is amongst the best of the industry. UHS outperforms 81.19% of its industry peers.
In the last couple of years the Operating Margin of UHS has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 11.01% | ||
| PM (TTM) | 7.66% | ||
| GM | N/A |
OM growth 3Y-0.49%
OM growth 5Y-0.12%
PM growth 3Y-2.68%
PM growth 5Y0.2%
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so UHS is still creating some value.
The number of shares outstanding for UHS has been reduced compared to 1 year ago.
UHS has less shares outstanding than it did 5 years ago.
UHS has a better debt/assets ratio than last year.
2.2 Solvency
UHS has an Altman-Z score of 3.23. This indicates that UHS is financially healthy and has little risk of bankruptcy at the moment.
With a decent Altman-Z score value of 3.23, UHS is doing good in the industry, outperforming 64.36% of the companies in the same industry.
The Debt to FCF ratio of UHS is 5.08, which is a neutral value as it means it would take UHS, 5.08 years of fcf income to pay off all of its debts.
The Debt to FCF ratio of UHS (5.08) is better than 68.32% of its industry peers.
A Debt/Equity ratio of 0.65 indicates that UHS is somewhat dependend on debt financing.
The Debt to Equity ratio of UHS (0.65) is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.65 | ||
| Debt/FCF | 5.08 | ||
| Altman-Z | 3.23 |
ROIC/WACC1.29
WACC8.55%
2.3 Liquidity
A Current Ratio of 1.29 indicates that UHS should not have too much problems paying its short term obligations.
UHS has a Current ratio (1.29) which is comparable to the rest of the industry.
A Quick Ratio of 1.19 indicates that UHS should not have too much problems paying its short term obligations.
UHS has a Quick ratio (1.19) which is comparable to the rest of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.29 | ||
| Quick Ratio | 1.19 |
3. Growth
3.1 Past
UHS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 40.07%, which is quite impressive.
The Earnings Per Share has been growing by 10.74% on average over the past years. This is quite good.
UHS shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 10.82%.
Measured over the past years, UHS shows a small growth in Revenue. The Revenue has been growing by 6.82% on average per year.
EPS 1Y (TTM)40.07%
EPS 3Y12.08%
EPS 5Y10.74%
EPS Q2Q%53.37%
Revenue 1Y (TTM)10.82%
Revenue growth 3Y7.78%
Revenue growth 5Y6.82%
Sales Q2Q%13.43%
3.2 Future
UHS is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.65% yearly.
Based on estimates for the next years, UHS will show a small growth in Revenue. The Revenue will grow by 4.70% on average per year.
EPS Next Y25.22%
EPS Next 2Y15.87%
EPS Next 3Y14%
EPS Next 5Y11.65%
Revenue Next Year9.48%
Revenue Next 2Y7.2%
Revenue Next 3Y6.46%
Revenue Next 5Y4.7%
3.3 Evolution
The EPS growth rate is stable: in the next years the growth will be about the same than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 10.29, the valuation of UHS can be described as very reasonable.
90.10% of the companies in the same industry are more expensive than UHS, based on the Price/Earnings ratio.
When comparing the Price/Earnings ratio of UHS to the average of the S&P500 Index (27.08), we can say UHS is valued rather cheaply.
With a Price/Forward Earnings ratio of 9.58, the valuation of UHS can be described as very reasonable.
Based on the Price/Forward Earnings ratio, UHS is valued cheaper than 90.10% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of UHS to the average of the S&P500 Index (23.09), we can say UHS is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.29 | ||
| Fwd PE | 9.58 |
4.2 Price Multiples
UHS's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. UHS is cheaper than 83.17% of the companies in the same industry.
77.23% of the companies in the same industry are more expensive than UHS, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 15.11 | ||
| EV/EBITDA | 7.5 |
4.3 Compensation for Growth
The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
The decent profitability rating of UHS may justify a higher PE ratio.
A more expensive valuation may be justified as UHS's earnings are expected to grow with 14.00% in the coming years.
PEG (NY)0.41
PEG (5Y)0.96
EPS Next 2Y15.87%
EPS Next 3Y14%
5. Dividend
5.1 Amount
UHS has a yearly dividend return of 0.38%, which is pretty low.
Compared to an average industry Dividend Yield of 2.42, UHS pays a bit more dividend than its industry peers.
With a Dividend Yield of 0.38, UHS pays less dividend than the S&P500 average, which is at 2.30.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.38% |
5.2 History
On average, the dividend of UHS grows each year by 6.27%, which is quite nice.
UHS has paid a dividend for at least 10 years, which is a reliable track record.
UHS has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)6.27%
Div Incr Years0
Div Non Decr Years4
5.3 Sustainability
UHS pays out 4.19% of its income as dividend. This is a sustainable payout ratio.
The dividend of UHS is growing, but earnings are growing more, so the dividend growth is sustainable.
DP4.19%
EPS Next 2Y15.87%
EPS Next 3Y14%
214.03
+3.35 (+1.59%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)
Earnings (Next)
Inst Owners98.12%
Inst Owner Change-0.51%
Ins Owners5.45%
Ins Owner Change14.58%
Market Cap13.62B
Revenue(TTM)15.83B
Net Income(TTM)1.26B
Analysts69.23
Price Target221.95 (3.7%)
Short Float %3.52%
Short Ratio2.89
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.38% |
Yearly Dividend0.81
Dividend Growth(5Y)6.27%
DP4.19%
Div Incr Years0
Div Non Decr Years4
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)8.89%
Min EPS beat(2)7.62%
Max EPS beat(2)10.15%
EPS beat(4)4
Avg EPS beat(4)8.74%
Min EPS beat(4)0.53%
Max EPS beat(4)16.65%
EPS beat(8)8
Avg EPS beat(8)11.9%
EPS beat(12)12
Avg EPS beat(12)9.02%
EPS beat(16)13
Avg EPS beat(16)5.35%
Revenue beat(2)1
Avg Revenue beat(2)-1.06%
Min Revenue beat(2)-2.29%
Max Revenue beat(2)0.18%
Revenue beat(4)3
Avg Revenue beat(4)0.01%
Min Revenue beat(4)-2.29%
Max Revenue beat(4)1.57%
Revenue beat(8)6
Avg Revenue beat(8)0.11%
Revenue beat(12)9
Avg Revenue beat(12)0.14%
Revenue beat(16)13
Avg Revenue beat(16)0.46%
PT rev (1m)-0.27%
PT rev (3m)-2.86%
EPS NQ rev (1m)2.79%
EPS NQ rev (3m)5.99%
EPS NY rev (1m)0.48%
EPS NY rev (3m)4.83%
Revenue NQ rev (1m)0.55%
Revenue NQ rev (3m)0.76%
Revenue NY rev (1m)0.16%
Revenue NY rev (3m)0.46%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 10.29 | ||
| Fwd PE | 9.58 | ||
| P/S | 0.83 | ||
| P/FCF | 15.11 | ||
| P/OCF | 7.17 | ||
| P/B | 1.94 | ||
| P/tB | 4.46 | ||
| EV/EBITDA | 7.5 |
EPS(TTM)20.8
EY9.72%
EPS(NY)22.34
Fwd EY10.44%
FCF(TTM)14.17
FCFY6.62%
OCF(TTM)29.86
OCFY13.95%
SpS258.65
BVpS110.47
TBVpS47.96
PEG (NY)0.41
PEG (5Y)0.96
Graham Number227.37
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 8.41% | ||
| ROE | 17.94% | ||
| ROCE | 14.3% | ||
| ROIC | 11.02% | ||
| ROICexc | 11.14% | ||
| ROICexgc | 16.33% | ||
| OM | 11.01% | ||
| PM (TTM) | 7.66% | ||
| GM | N/A | ||
| FCFM | 5.48% |
ROA(3y)6.01%
ROA(5y)6.51%
ROE(3y)13.4%
ROE(5y)14.27%
ROIC(3y)8.28%
ROIC(5y)8.76%
ROICexc(3y)8.36%
ROICexc(5y)9.07%
ROICexgc(3y)12.5%
ROICexgc(5y)14.04%
ROCE(3y)10.74%
ROCE(5y)11.37%
ROICexgc growth 3Y1.9%
ROICexgc growth 5Y0.81%
ROICexc growth 3Y3.79%
ROICexc growth 5Y2.74%
OM growth 3Y-0.49%
OM growth 5Y-0.12%
PM growth 3Y-2.68%
PM growth 5Y0.2%
GM growth 3YN/A
GM growth 5YN/A
F-Score9
Asset Turnover1.1
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.65 | ||
| Debt/FCF | 5.08 | ||
| Debt/EBITDA | 1.89 | ||
| Cap/Depr | 167.41% | ||
| Cap/Sales | 6.07% | ||
| Interest Coverage | 12.09 | ||
| Cash Conversion | 78.91% | ||
| Profit Quality | 71.49% | ||
| Current Ratio | 1.29 | ||
| Quick Ratio | 1.19 | ||
| Altman-Z | 3.23 |
F-Score9
WACC8.55%
ROIC/WACC1.29
Cap/Depr(3y)139.45%
Cap/Depr(5y)144.53%
Cap/Sales(3y)5.55%
Cap/Sales(5y)5.95%
Profit Quality(3y)70.11%
Profit Quality(5y)77.19%
High Growth Momentum
Growth
EPS 1Y (TTM)40.07%
EPS 3Y12.08%
EPS 5Y10.74%
EPS Q2Q%53.37%
EPS Next Y25.22%
EPS Next 2Y15.87%
EPS Next 3Y14%
EPS Next 5Y11.65%
Revenue 1Y (TTM)10.82%
Revenue growth 3Y7.78%
Revenue growth 5Y6.82%
Sales Q2Q%13.43%
Revenue Next Year9.48%
Revenue Next 2Y7.2%
Revenue Next 3Y6.46%
Revenue Next 5Y4.7%
EBIT growth 1Y25.67%
EBIT growth 3Y7.25%
EBIT growth 5Y6.7%
EBIT Next Year55.52%
EBIT Next 3Y19.2%
EBIT Next 5YN/A
FCF growth 1Y77.13%
FCF growth 3Y242.18%
FCF growth 5Y7.48%
OCF growth 1Y62.2%
OCF growth 3Y32.75%
OCF growth 5Y7.52%
UNIVERSAL HEALTH SERVICES-B / UHS FAQ
What is the fundamental rating for UHS stock?
ChartMill assigns a fundamental rating of 6 / 10 to UHS.
What is the valuation status for UHS stock?
ChartMill assigns a valuation rating of 8 / 10 to UNIVERSAL HEALTH SERVICES-B (UHS). This can be considered as Undervalued.
What is the profitability of UHS stock?
UNIVERSAL HEALTH SERVICES-B (UHS) has a profitability rating of 7 / 10.
Can you provide the PE and PB ratios for UHS stock?
The Price/Earnings (PE) ratio for UNIVERSAL HEALTH SERVICES-B (UHS) is 10.29 and the Price/Book (PB) ratio is 1.94.
Can you provide the financial health for UHS stock?
The financial health rating of UNIVERSAL HEALTH SERVICES-B (UHS) is 6 / 10.